Insulin-mediated vasodilation and glucose uptake are functionally linked in humans

Hypertension

Volumn 33, Issue 1 II, 1999, Pages 554-558

  Cleland, Stephen J ^a,b   Petrie, John R ^a   Ueda, Shinichiro ^a   Elliott, Henry L ^a   Connell, John M C ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b WESTERN INFIRMARY   (United Kingdom)

Author keywords

Endothelial function; Euglycemic clamp; Forearm blood flow; Human study; Insulin resistance; Plethysmography

Indexed keywords

INSULIN;

ADULT; ARTICLE; BLOOD FLOW VELOCITY; BODY MASS; FOREARM BLOOD FLOW; GLUCOSE TRANSPORT; HUMAN; HUMAN EXPERIMENT; INSULIN SENSITIVITY; MALE; NORMAL HUMAN; PLETHYSMOGRAPHY; PRIORITY JOURNAL; VASODILATATION; VASOMOTOR REFLEX;

EID: 0032957705     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.33.1.554     Document Type: Article

References (48)

1. De Fronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14:173-194.
2. Yki-Jarvinen H, Koivisto VA. Effect of body composition on insulin sensitivity. Diabetes. 1983;32:965-969.
3. De Fronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM; a balanced overview. Diabetes Care. 1992;15:316-368.
4. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S. Insulin resistance in essential hypertension. N Engl J Med. 1987;317:350-357.
5. Swan JW, Walton C, Godsland IF, Clark AL, Coats AJS, Oliver MF. Insulin resistance in chronic heart failure. Eur Heart J. 1994;15: 1528-1532.
6. Williams SB, Cusco JA, Roddy M, Johnstone MT, Creager MA. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol. 1996;27:567-574.
7. G-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal. J Hypertens. 1992;10:1025-1031.
8. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation. 1993;87: 1468-1474.
9. Drexler H, Hayoz D, Munzel T, Just H, Zelis R, Brunner HR. Endothelial function in congestive heart failure. Am Heart J. 1993;126(suppl II): 761-764.
10. Clark MG, Colquhoun EQ, Rattigan S, Dora KA, Eldershaw TPD, Hall JL, Ye J. Vascular and endocrine control of muscle metabolism. Am J Physiol. 1995;268:E797-E812.
11. Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P. Nitric oxide release accounts for insulin's vascular effects in humans. J Clin Invest. 1994;94:2511-2515.
12. Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent: a novel action of insulin to increase nitric oxide release. J Clin Invest. 1994;94: 1172-1179.
13. Graier WF, Wascher TC, Lackener L, Tplak H, Krejs GJ, Kukovetz WR. Exposure to elevated D-glucose concentrations modulates vascular endothelial cell vasodilatory response. Diabetes. 1993;42:1497-1505.
14. +) and nitric oxide synthase by elevated glucose and insulin in human endothelial cells. J Physiol. 1996;490:775-781.
15. Zeng G, Quon MJ. Insulin-stimulated production of nitric oxide is inhibited by wortmannin. J Clin Invest. 1996;98:894-898.
16. Velloso LA, Folli F, Sun XJ, White MF, Saad MJA, Kahn CR. Cross-talk between the insulin and angiotensin signaling systems. Proc Natl Acad Sci U S A. 1996;93:12490-12495.
17. Young ME, Leighton B. Evidence for altered sensitivity of the nitric oxide/cGMP signalling cascade in insulin-resistant skeletal muscle. Biochem J. 1998;329:73-39.
18. Petrie J, Ueda S, Webb DJ, Elliott HL, Connell JMC. Endothelial nitric oxide production and insulin sensitivity: a physiological link with implications for pathogenesis of cardiovascular disease. Circulation. 1996;93: 1331-1333.
19. Steinberg HO, Chaker H, Learning R, Johnson A, Brechtel G, Baron AD. Obesity/insulin resistance is associated with endothelial dysfunction. J Clin Invest. 1996;97:2601-2610.
20. Utriainen TR, Makimattila S, Virkamaki A, Bergholm R, Yki-Jarvinen H. Dissociation between insulin sensitivity of glucose uptake and endothelial function in normal subjects. Diabetologia. 1996;39:1477-1482.
21. Utnainen T, Makimattila S, Virkamalu A, Lindholm H, Sovijarvi A, Yki-Jarvinen H. Physical fitness and endothelial function (nitric oxide synthesis) are independent determinants of insulin-stimulated blood flow in man. J Clin Endocrinol Metab. 1996;81:4258-4263.
22. Raitakari M, Nuutila P, Ruotsalainen U, Laine H, Teras M, Iida H, Makimattila S, Utriainen T, Oikonen V, Sipila H, Haaparanta M, Solin O, Wegelius U, Knuuti J, Yki-Jarvinen H. Evidence for dissociation of insulin stimulation of blood flow and glucose uptake in human skeletal muscle. Diabetes. 1996;45:1471-1477.
23. Baron AD, Steinberg HO, Chaker H, Learning R, Johnson A, Brechtel G. Insulin-mediated skeletal muscle vasodilation contributes to both insulin sensitivity and responsiveness in lean humans. J Clin Invest. 1995;96: 786-792.
24. Bonadonna RC, Saccomani MP, Del Prato S, Bonora E, DeFronzo RA, Cobelli C. Role of tissue-specific blood flow and tissue recruitment in insulin-mediated glucose uptake of human skeletal muscle. Circulation. 1998;98:234-241.
25. Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest. 1991;87:2246-2252.
26. Muscelli E, Emdin M, Natali A, Pratali L, Camastra S, Gastaldelli A, Baldi S, Carpeggiani C, Ferrannini E. Autonomic and hemodynamic responses to insulin in lean and obese humans. J Clin Endocrinol Metab. 1998;83:2084-2090.
27. Creager MA, Liang C, Coffman JD. Beta adrenergic-mediated vasodilator response to insulin in the human forearm. J Pharmacol Exp Ther. 1985; 235:709-714.
28. Natali A, Santoro D, Palombo C, Cerri M, Ghione S, Ferrannini E. Impaired insulin action on skeletal muscle metabolism in essential hypertension. Hypertension. 1991;17:170-178.
29. Sakai K, Imaizumi T, Masaki H, Takeshita A. Intra-arterial infusion of insulin attenuates vasoreactivity in human forearm. Hypertension. 1993;22:67-73.
30. Neahring JM, Stepniakowski K, Greene AS, Egan BM. Insulin does not reduce forearm α-vasoreactivity in obese hypertensive or lean normotensive men. Hypertension. 1993;22:584-590.
31. Tack CJ, Lutterman JA, Vervoort G, Thien T, Smits P. Activation of the sodium-potassium pump contributes to insulin-induced vasodilation in humans. Hypertension. 1996;28:426-432.
32. Ueda S, Petrie JR, Cleland SJ, Elliott HL, Connell JMC. Insulin-mediated vasodilatation is dependent on local glucose uptake: a double-blind, placebo-controlled study. J Clin Endocrinol Metab. 1998;83:2126-2131.
33. Defronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237: E214-E223.
34. Benjamin N, Calver A, Collier J, Robinson B, Vallance P, Webb D. Measuring forearm blood flow and interpreting the responses to drugs and mediators. Hypertension. 1995;25:918-923.
35. Matthews JNS, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. BMJ. 1990;300:230-235.
36. Utriainen T, Nuutila P, Takala T, Vicini P, Ruotsalainen U, Ronnemaa T, Tolvanen T, Raitakari M, Haaparanta M, Kirvela O, Cobelli C, Yki-Jarvinen H. Intact insulin stimulation of skeletal muscle blood flow, its heterogeneity and redistribution, but not of glucose uptake in non-insulin-dependent diabetes mellitus. J Gin Invest. 1997;100:777-785.
37. Sowers JR. Effects of insulin and IGF-1 on vascular smooth muscle glucose and cation metabolism. Diabetes. 1996;45(suppl 3):S47-S51.
38. + ATPase. J Hypertens. 1997;15(suppl 4):S71. Abstract.
39. Tack CJ, Lutterman JA, Vervoort G, Thien T, Smits P. Activation of the sodium-potassium pump contributes to insulin-induced vasodilation in humans. Hypertension. 1996;28:426-432.
40. Baron AD. Cardiovascular actions of insulin in humans. Implications for insulin sensitivity and vascular tone. Bailliere's Clin Endocrinol Metab 1993;7:961-987.
41. 2+ influx and contraction in vascular smooth muscle. Circulation. 1995;92:1597-1603.
42. Vollenweider P, Tappy L, Randin D, Schneiten P, Jequier E, Nicod P, Scherrer U. Differential effects of hyperinsulinaemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans. J Clin Invest. 1993;92:147-154.
43. Baron A. Hemodynamic actions of insulin. Am J Physiol. 1994:267-E187-E202.
44. Yki-Jarvinen H. Role of insulin resistance in the pathogenesis of NIDDM. Diabetologia. 1995;38:1378-1388.
45. Mijares AH, Jensen MD. Contribution of blood flow to leg glucose uptake during a mixed meal. Diabetes. 1995;44:1165-1169.
46. Kelly D, Mitrakou A, Marsh H, Schwenk F, Benn J, Sonnenberg G, Arcangeli M, Aoki T, Sorensel J, Berger M, Sonksen P, Gerich J. Skeletal muscle glycolysis, oxidation, and storage of an oral glucose load. J Clin Invest. 1988;81:1563-1571.
47. Natali A, Bonadonna R, Santoro D, Galvan AQ, Baldi S, Frascerra S, Palombo C, Ghione S, Ferrannini E. Insulin resistance and vasodilation in essential hypertension: studies with adenosine. J Clin Invest 1994;94: 1570-1576.
48. 18F]fluorodeoxy-glucose and positron emission tomography. J Clin Invest. 1996; 97:1741-1747.